Showing 1 to 10 of 69 results
A major advance in treating spinal cord injuries by using genetically modified human neural stem cells has been made by a team co-led by CityU and the University of Hong Kong.
Four academics from CityU have been successful under the Senior Research Fellow Scheme and the Research Fellow Scheme (2023/24) established by RGC.
Researchers at CityU have identified and demonstrated for the first time a therapeutic small molecule, M1, that can restore the visual function in the mammalian central nervous system, offering hope for patients with optic nerve damage such as glaucoma-related vision loss.
Researchers at CityU received tremendous accolades at Inventions Geneva Evaluation Days (IGED) 2022 by winning a total of 22 awards, the highest number among local institutions for two years in a row.
Researchers from CityU won the highest number of awards among all universities in Hong Kong at IGED 2021, including a Gold Medal with Congratulations of the Jury, five Gold Medals, three Silver Medals and three Bronze Medals, demonstrating the excellence of the research carried out at CityU.
Professor Sir Colin Blakemore delivered his talk in the President’s Lecture Series: Excellence in Academia.
Scientists working on a project led by CityU have found a way to develop novel materials by manipulating the nanoscale structure of metallic glass.
A novel gene vector developed by a CityU PhD student, enhances the efficiency of delivering gene therapy and chemotherapy drugs into cancer cells.
A pioneering summer course on neutron scattering held at CityU and funded by the Croucher Foundation will advance research into this powerful tool.
CityU ranks 2nd in Hong Kong in terms of the number of Highly Cited Researchers named in the list of Highly Cited Researchers 2014 published by Thomson Reuters.